We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$456M
AUM Growth
Cap. Flow
+$445M
Cap. Flow %
97.71%
Top 10 Hldgs %
40.34%
Holding
131
New
131
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 19.5%
2 Consumer Discretionary 11.75%
3 Technology 10.69%
4 Industrials 9.31%
5 Materials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBBN icon
126
Ribbon Communications
RBBN
$377M
$90K 0.02%
+6,000
New +$80.1K
VNDA icon
127
Vanda Pharmaceuticals
VNDA
$307M
$81K 0.02%
+10,000
New +$67.3K
WWR icon
128
Westwater Resources
WWR
$52.4M
$66K 0.01%
+42
New +$59.9K
URZ
129
DELISTED
URANERZ ENERGY CORP
URZ
$55K 0.01%
+50,000
New +$59.1K
HIMX
130
Himax Technologies
HIMX
$2.19B
$52K 0.01%
+10,000
New +$61.5K
DYAX
131
DELISTED
DYAX CORPORATION
DYAX
$52K 0.01%
+15,000
New +$49K

Similar funds

Ardsley Advisory Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Ardsley Advisory Partners, which disclosed 131 positions worth $456M. Its ten largest holdings account for 40% of the portfolio.

Its largest position is Jazz Pharmaceuticals: 433,500 shares worth $29.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Consumer Discretionary and Technology.

  • Ardsley Advisory Partners's largest Q2 2013 buy was Jazz Pharmaceuticals: 433,500 shares worth $29.8M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $456M portfolio in Q2 2013.
  • Ardsley Advisory Partners disclosed 131 positions in Q2 2013, its first 13F filing on record.

Based on Ardsley Advisory Partners's 13F filing for Q2 2013, filed 14 Aug 2013.